Labcon North America

The Carbon Impact of the Biotech and Pharma supply chain & reducing it via informed procurement decisions.

The Carbon Impact of the Biotech and Pharma industry is larger than both the Semiconductor and Forestry & Paper industries. Within this, Scope 3 emissions and predominantly supply chain are 5 * bigger than Scope 1+2 (operational) carbon emissions. We will present the data behind these findings, concepts around reducing this impact and the ACT. Eco Label. ACT is a tool that enables informed sustainable laboratory procurement and facilitates manufacturers in measuring and improving their product sustainability.

Themen: Energie / Umwelt / Wasser
Veranstaltungstyp: Vortrag


01:00 (30 Minuten)
Halle B1.141